A

ABL Bio Inc
KOSDAQ:298380

Watchlist Manager
ABL Bio Inc
KOSDAQ:298380
Watchlist
Price: 31 500 KRW -4.69%
Market Cap: 1.5T KRW
Have any thoughts about
ABL Bio Inc?
Write Note

ABL Bio Inc
Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

ABL Bio Inc
Operating Expenses Peer Comparison

Comparables:
068270
302440
H
145020
P
214450
196170

Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
A
ABL Bio Inc
KOSDAQ:298380
Operating Expenses
-â‚©60.1B
CAGR 3-Years
2%
CAGR 5-Years
-34%
CAGR 10-Years
N/A
Celltrion Inc
KRX:068270
Operating Expenses
-â‚©816.5B
CAGR 3-Years
-32%
CAGR 5-Years
-29%
CAGR 10-Years
-23%
SK Bioscience Co Ltd
KRX:302440
Operating Expenses
-â‚©154.2B
CAGR 3-Years
-39%
CAGR 5-Years
-45%
CAGR 10-Years
N/A
H
Hugel Inc
KOSDAQ:145020
Operating Expenses
-â‚©124.1B
CAGR 3-Years
-17%
CAGR 5-Years
-16%
CAGR 10-Years
N/A
P
PharmaResearch Co Ltd
KOSDAQ:214450
Operating Expenses
-â‚©108.8B
CAGR 3-Years
-32%
CAGR 5-Years
-29%
CAGR 10-Years
N/A
Alteogen Inc
KOSDAQ:196170
Operating Expenses
-â‚©42.7B
CAGR 3-Years
-16%
CAGR 5-Years
-28%
CAGR 10-Years
N/A

See Also

What is ABL Bio Inc's Operating Expenses?
Operating Expenses
-60.1B KRW

Based on the financial report for Jun 30, 2024, ABL Bio Inc's Operating Expenses amounts to -60.1B KRW.

What is ABL Bio Inc's Operating Expenses growth rate?
Operating Expenses CAGR 5Y
-34%

Over the last year, the Operating Expenses growth was 3%. The average annual Operating Expenses growth rates for ABL Bio Inc have been 2% over the past three years , -34% over the past five years .

Back to Top